173 related articles for article (PubMed ID: 27623556)
1. Identification of Novel Serum Autoantibodies for Differential Diagnosis of Autoimmune Pancreatitis and Pancreatic Ductal Adenocarcinoma.
Felix K; Hauck O; Schnölzer M; Kempf T; Warnken U; Schneider K; Bergmann F; Fritz S; Werner J
Pancreas; 2016 Oct; 45(9):1309-19. PubMed ID: 27623556
[TBL] [Abstract][Full Text] [Related]
2. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
[TBL] [Abstract][Full Text] [Related]
3. Novel Autoantibody Signatures in Sera of Patients with Pancreatic Cancer, Chronic Pancreatitis and Autoimmune Pancreatitis: A Protein Microarray Profiling Approach.
Ghassem-Zadeh S; Hufnagel K; Bauer A; Frossard JL; Yoshida M; Kutsumi H; Acha-Orbea H; Neulinger-Muñoz M; Vey J; Eckert C; Strobel O; Hoheisel JD; Felix K
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244327
[TBL] [Abstract][Full Text] [Related]
4. Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels.
Felix K; Dobiasch S; Gaida MM; Schneider K; Werner J; Martens E; Vandooren J; Opdenakker G
Pancreas; 2016 Aug; 45(7):1048-55. PubMed ID: 26692441
[TBL] [Abstract][Full Text] [Related]
5. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
[TBL] [Abstract][Full Text] [Related]
6. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
[TBL] [Abstract][Full Text] [Related]
7. Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.
Park S; Chu LC; Hruban RH; Vogelstein B; Kinzler KW; Yuille AL; Fouladi DF; Shayesteh S; Ghandili S; Wolfgang CL; Burkhart R; He J; Fishman EK; Kawamoto S
Diagn Interv Imaging; 2020 Sep; 101(9):555-564. PubMed ID: 32278586
[TBL] [Abstract][Full Text] [Related]
8. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
Akamatsu M; Makino N; Ikeda Y; Matsuda A; Ito M; Kakizaki Y; Saito Y; Ishizawa T; Kobayashi T; Furukawa T; Ueno Y
PLoS One; 2016; 11(7):e0158669. PubMed ID: 27380024
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing pancreatic cancer and autoimmune pancreatitis with in vivo tomoelastography.
Zhu L; Guo J; Jin Z; Xue H; Dai M; Zhang W; Sun Z; Xu J; Marticorena Garcia SR; Asbach P; Hamm B; Sack I
Eur Radiol; 2021 May; 31(5):3366-3374. PubMed ID: 33125553
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas.
Kim HJ; Kim YK; Jeong WK; Lee WJ; Choi D
Eur Radiol; 2015 Jun; 25(6):1551-60. PubMed ID: 25501271
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic ductal adenocarcinoma with autoimmune pancreatitis-like histologic and immunohistochemical features.
Zhang X; Liu X; Joseph L; Zhao L; Hart J; Xiao SY
Hum Pathol; 2014 Mar; 45(3):621-7. PubMed ID: 24457081
[TBL] [Abstract][Full Text] [Related]
12. High accuracy differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma by immunoglobulin G glycosylation.
Shih HC; Chang MC; Chen CH; Tsai IL; Wang SY; Kuo YP; Chen CH; Chang YT
Clin Proteomics; 2019; 16():1. PubMed ID: 30622446
[TBL] [Abstract][Full Text] [Related]
13. Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
Marya NB; Powers PD; Chari ST; Gleeson FC; Leggett CL; Abu Dayyeh BK; Chandrasekhara V; Iyer PG; Majumder S; Pearson RK; Petersen BT; Rajan E; Sawas T; Storm AC; Vege SS; Chen S; Long Z; Hough DM; Mara K; Levy MJ
Gut; 2021 Jul; 70(7):1335-1344. PubMed ID: 33028668
[TBL] [Abstract][Full Text] [Related]
14. MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
Ha J; Choi SH; Kim KW; Kim JH; Kim HJ
Dig Liver Dis; 2022 Jul; 54(7):849-856. PubMed ID: 34903501
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis.
Yoon SB; Jeon TY; Moon SH; Shin DW; Lee SM; Choi MH; Min JH; Kim MJ
Eur Radiol; 2023 Dec; 33(12):9010-9021. PubMed ID: 37466708
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of autoimmune pancreatitis types 1 and 2.
Fritz S; Bergmann F; Grenacher L; Sgroi M; Hinz U; Hackert T; Büchler MW; Werner J
Br J Surg; 2014 Sep; 101(10):1257-65. PubMed ID: 25047016
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of CT and MRI for differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma.
Ha J; Choi SH; Byun JH; Kim KW; Kim SY; Kim JH; Kim HJ
Eur Radiol; 2021 May; 31(5):3427-3438. PubMed ID: 33146798
[TBL] [Abstract][Full Text] [Related]
18. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
Jia H; Li J; Huang W; Lin G
BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
[TBL] [Abstract][Full Text] [Related]
19. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
20. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
